Current Cardiology Reports

, 9:406

The risk of drug-eluting stent thrombosis with noncardiac surgery

  • Emmanouil S. Brilakis
  • Subhash Banerjee
  • Peter B. Berger
Inverventional Cardiology

DOI: 10.1007/BF02938368

Cite this article as:
Brilakis, E.S., Banerjee, S. & Berger, P.B. Curr Cardiol Rep (2007) 9: 406. doi:10.1007/BF02938368

Abstract

Patients in whom any kind of stent, particularly a drug-eluting stent (DES), was recently implanted are at risk for stent thrombosis when they undergo noncardiac surgery, even months or years after their implantation. The risk of DES thrombosis is likely decreased by delaying noncardiac surgery for as long as possible and continuing dual or at least single antiplatelet therapy in the perioperative period. Preoperative identification and close monitoring of patients with DES may allow prevention and prompt detection and treatment of this catastrophic complication.

Copyright information

© Current Medicine Group LLC 2007

Authors and Affiliations

  • Emmanouil S. Brilakis
    • 1
  • Subhash Banerjee
  • Peter B. Berger
  1. 1.Dallas VA Medical Center (111A)DallasUSA